Literature DB >> 32234539

Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors.

Roberto Manganaro1, Birgit Zonsics1, Lisa Bauer2, Moira Lorenzo Lopez1, Tim Donselaar2, Marleen Zwaagstra2, Fabiana Saporito1, Salvatore Ferla1, Jeroen R P M Strating2, Bruno Coutard3, Daniel L Hurdiss2, Frank J M van Kuppeveld2, Andrea Brancale4.   

Abstract

Enteroviruses (EV) are a group of positive-strand RNA (+RNA) viruses that include many important human pathogens (e.g. poliovirus, coxsackievirus, echovirus, numbered enteroviruses and rhinoviruses). Fluoxetine was identified in drug repurposing screens as potent inhibitor of enterovirus B and enterovirus D replication. In this paper we are reporting the synthesis and the antiviral effect of a series of fluoxetine analogues. The results obtained offer a preliminary insight into the structure-activity relationship of its chemical scaffold and confirm the importance of the chiral configuration. We identified a racemic fluoxetine analogue, 2b, which showed a similar antiviral activity compared to (S)-fluoxetine. Investigating the stereochemistry of 2b revealed that the S-enantiomer exerts potent antiviral activity and increased the antiviral spectrum compared to the racemic mixture of 2b. In line with the observed antiviral effect, the S-enantiomer displayed a dose-dependent shift in the melting temperature in thermal shift assays, indicative for direct binding to the recombinant 2C protein.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2C Inhibitors; Enterovirus; Fluoxetine; Thermal shift assay

Year:  2020        PMID: 32234539     DOI: 10.1016/j.antiviral.2020.104781

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  10 in total

1.  Biochemical and structural characterization of hepatitis A virus 2C reveals an unusual ribonuclease activity on single-stranded RNA.

Authors:  Pu Chen; Justyna Aleksandra Wojdyla; Ombretta Colasanti; Zhijian Li; Bo Qin; Meitian Wang; Volker Lohmann; Sheng Cui
Journal:  Nucleic Acids Res       Date:  2022-08-10       Impact factor: 19.160

2.  Enterovirus A71 antivirals: Past, present, and future.

Authors:  Jun Wang; Yanmei Hu; Madeleine Zheng
Journal:  Acta Pharm Sin B       Date:  2021-08-20       Impact factor: 14.903

Review 3.  Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?

Authors:  Yaser Pashaei
Journal:  J Clin Neurosci       Date:  2021-03-19       Impact factor: 1.961

4.  Fluoxetine targets an allosteric site in the enterovirus 2C AAA+ ATPase and stabilizes a ring-shaped hexameric complex.

Authors:  Daniel L Hurdiss; Priscila El Kazzi; Lisa Bauer; Nicolas Papageorgiou; François P Ferron; Tim Donselaar; Arno L W van Vliet; Tatiana M Shamorkina; Joost Snijder; Bruno Canard; Etienne Decroly; Andrea Brancale; Tzviya Zeev-Ben-Mordehai; Friedrich Förster; Frank J M van Kuppeveld; Bruno Coutard
Journal:  Sci Adv       Date:  2022-01-05       Impact factor: 14.136

Review 5.  Role of Lipid Rafts in Pathogen-Host Interaction - A Mini Review.

Authors:  Rakesh Kulkarni; Erik A C Wiemer; Wen Chang
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

6.  Fighting Enteroviral Infections to Prevent Type 1 Diabetes.

Authors:  Magloire Pandoua Nekoua; Ambroise Mercier; Abdulaziz Alhazmi; Famara Sane; Enagnon Kazali Alidjinou; Didier Hober
Journal:  Microorganisms       Date:  2022-04-01

7.  Structure Prediction and Potential Inhibitors Docking of Enterovirus 2C Proteins.

Authors:  Daoqun Li; Leiliang Zhang
Journal:  Front Microbiol       Date:  2022-04-29       Impact factor: 5.640

8.  Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.

Authors:  Franck Touret; Jean-Sélim Driouich; Maxime Cochin; Paul Rémi Petit; Magali Gilles; Karine Barthélémy; Grégory Moureau; Francois-Xavier Mahon; Denis Malvy; Caroline Solas; Xavier de Lamballerie; Antoine Nougairède
Journal:  Antiviral Res       Date:  2021-07-12       Impact factor: 5.970

9.  Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C.

Authors:  Lisa Bauer; Roberto Manganaro; Birgit Zonsics; Daniel L Hurdiss; Marleen Zwaagstra; Tim Donselaar; Naemi G E Welter; Regina G D M van Kleef; Moira Lorenzo Lopez; Federica Bevilacqua; Thamidur Raman; Salvatore Ferla; Marcella Bassetto; Johan Neyts; Jeroen R P M Strating; Remco H S Westerink; Andrea Brancale; Frank J M van Kuppeveld
Journal:  PLoS Biol       Date:  2020-11-06       Impact factor: 8.029

Review 10.  Rhinovirus Inhibitors: Including a New Target, the Viral RNA.

Authors:  Antonio Real-Hohn; Dieter Blaas
Journal:  Viruses       Date:  2021-09-07       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.